Mark Souweidane
New York, NY, USA
Weill Cornell Medicine
About
Vice Chairman, Neurological Surgery; Director, Pediatric Neurological Surgery
Weill Cornell Medicine Pediatric Brain & Spine Center
Dr. Souweidane oversees a translational laboratory focusing on improving methods for treating children with incurable brain tumors. His work is nationally regarded for the development of drug delivery techniques for childhood brain tumors that are not amenable to surgical removal. He is the principal investigator (PI) for clinical trials using direct delivery as a novel therapeutic approach. He supplements his laboratory research with clinical projects, both independently and as a member of multi-institutional studies, including the Children’s Oncology Group (COG) and the Pediatric Brain Tumor Consortium (PBTC).
Weill Cornell Medicine
research
Interests
Craniopharyngioma
Childhood craniopharyngiomas are rare tumors usually found near the pituitary gland (a pea-sized organ at the bottom of the brain that controls other glands) and the hypothalamus (a small cone-shaped organ connected to the pituitary gland by nerves).Craniopharyngiomas are usually part solid mass and
Atypical Teratoid/Rhabdoid Tumor
Central nervous system (CNS) atypical teratoid/rhabdoid tumor (AT/RT) is a very rare, fast-growing tumor of the brain and spinal cord. It usually occurs in children aged three years and younger, although it can occur in older children and adults. About half of these tumors form in the cerebellum or
Diffuse Intrinsic Pontine Glioma
A presumptive diagnosis of DIPG based on classic imaging features, in the absence of a histologic diagnosis, has been routinely employed. Increasingly however, histologic confirmation is obtained for both entry into research studies and molecular characterization of the tumor.[5] New approaches with
